SNAP Update and ResourcesActualización y recursos de SNAP
On November 1, 2025, the requirements to receive and apply to the Supplemental Nutrition Assistance Program (SNAP) benefits have changed. To see the new policies to request SNAP benefits, click here and/or call 211 for SNAP assistance. Learn more
El 1 de noviembre de 2025, cambiaron los requisitos para recibir y aplicar para los beneficios del Programa de Asistencia Nutricional Suplementaria (SNAP, por sus siglas en inglés). Para consultar las nuevas políticas para aplicar para los beneficios de SNAP, haz clic aquí o llama al 211 para obtener ayuda de SNAP. Aprende Más
Transportation UpdateActualización de transporte
Starting December 15, 2025, SafeRide Health will become the new provider for all member rides to doctor appointments and pharmacy visits. After this date, Texas Children’s Health Plan will no longer use MTM for Non Emergency Medical Transportation (NEMT) services.
For other questions, please call Member Services at the number on the back of your member ID card.
A partir del 15 de diciembre de 2025, SafeRide Health será el nuevo proveedor para todos los viajes de los miembros a citas médicas y visitas a la farmacia. Después de esta fecha, Texas Children’s Health Plan ya no usará MTM para los servicios de Transporte Médico No Urgente (NEMT).
Addition of Paxlovid (Pfizer Oral Covid-19 Drug) to Formulary
Date: January 8, 2024
Attention: Providers
Effective date: January 4, 2024
Call to action: Texas Children’s Health Plan (TCHP) would like to let providers know that effective January 4, 2024, the Texas Health and Human Services (HHS) added Paxlovid to the formulary.
Paxlovid (nirmatrelvir co-packaged with ritonavir) is an oral antiviral tablet, is indicated for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including hospitalization or death.
How this impacts providers:
Please see below for the list of impacted drugs (of note, the approval is NDC-specific):
Medication
Medication NDC
Type of Change
Effective Date
PAXLOVID 150-100 MG DOSE PACK
00069531720
FORMULARY ADDITION
January 4, 2024
PAXLOVID 300-100 MG DOSE PACK
00069532130
FORMULARY ADDITION
January 4, 2024
Next step for Providers: Prescribers are encouraged to educate patients about Paxlovid, including the importance of early intervention and adherence to prescribed treatment regimens. For detailed information on Paxlovid, including prescribing information and eligibility criteria, please refer to the drug’s official prescribing information.
